SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...
Shortly after securing an FDA clearance last month for its simple, self-operated blood sample collection device, Tasso has teamed up with Catapult Health to help propel its device into people’s homes.
The test includes the Weavr Velvet blood collection device, which separates the sample into its red blood cell and plasma components. Labcorp has launched the Diabetes Risk (HbA1c) at-home collection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results